Compliance with the Gluten-Free Diet: The Role of Locus of Control in Celiac Disease - 20/08/11
, Chiara Zanchi, MD , Stefano Martelossi, MD, Grazia Di Leo, MD, Tarcisio Not, MD ⁎ 
, Alessandro Ventura, MDReprint requests: Tarcisio Not, MD, Immunopathological Laboratory, Children’s Hospital, IRCCS “Burlo Garofolo,” Via dell’Istria 65/1, IT-34100 Trieste, Italy.Abstract |
Objectives |
To verify whether subjects with celiac disease (CD) have a different locus of control (LoC) compared with healthy subjects, and to evaluate the relationship between LoC and compliance with a prescribed gluten-free diet (GFD) and quality of life (QoL).
Study design |
We studied 156 subjects on a GFD (mean age, 10 years) and 353 healthy controls (mean age, 12 years). All subjects completed tests on the Nowicki-Strickland Locus of Control Scale; the subjects with CD also completed a questionnaire to measure compliance with dietary treatment and the disease’s impact on QoL.
Results |
There was no difference in LoC values between patients with CD and controls. Subjects with CD with good dietary compliance had a more internal LoC compared with those who were not compliant (P = .01). Patients who reported a satisfactory QoL had a more internal LoC compared with those who reported negative affects on QoL due to CD (P = .01).
Conclusions |
Our study confirms the usefulness of the LoC concept for identifying those patients who might be at risk for dietary transgression. Given the enhanced, psychological, and social well being that can result from adherence to a GFD, educational and psychological support can help internalize the LoC in those patients at risk for dietary transgression.
Le texte complet de cet article est disponible en PDF.Mots-clés : Anti-tTG, CD, GFD, LoC, NSLCS, QoL
Plan
| Supported by Grant 36/08 from the Institute of Child Health, IRCCS “Burlo Garofolo.” The authors have no conflicts of interest to disclose. |
Vol 158 - N° 3
P. 463 - mars 2011 Retour au numéro
Article précédent
- Rosuvastatin Lowers Coenzyme Q10 Levels, but not Mitochondrial Adenosine Triphosphate Synthesis, in Children with Familial Hypercholesterolemia
- Hans J. Avis, Ian P. Hargreaves, Jos P.N. Ruiter, John M. Land, Ronald J. Wanders, Frits A. Wijburg
- Childhood Onset Inflammatory Bowel Disease: Predictors of Delayed Diagnosis from the CEDATA German-Language Pediatric Inflammatory Bowel Disease Registry
- Antje Timmer, Rolf Behrens, Stephan Buderus, Annette Findeisen, Almuthe Hauer, Klaus-Michael Keller, Guido Kliemann, Thomas Lang, Wolfgang Lohr, Peter Rzehak, Sibylle Koletzko, CEDATA-GPGE Study Group ∗
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?